20 likes | 35 Views
The Small Cell Lung Cancer Market Size is Expected to Increase at a CAGR of 13.2% for the Study Period (2017-2030) in the 7MM.<br><br>The total incident cases of Small Cell Lung Cancer were 85,540 in 7MM IN 2017.<br><br>The key players in the Small Cell Lung Cancer Market include AstraZeneca, PharmaMar, EpicentRx, United Therapeutics, Ipsen, G1 Therapeutics, Otsuka Holdings, Takeda and others.<br><br>For more details visit: <br>https://www.delveinsight.com/report-store/small-cell-lung-cancer-market#infographics<br><br>
E N D